Corautus Genetics will move to the Nasdaq, effective Wednesday.

The company’s new symbol will be VEGF.

Corautus currently trades on Amex under the symbol Caq.

“Our move to NASDAQ is an important part of our plan to gain more visibility for Corautus Genetics and increase the liquidity of our shares,” said Richard Otto, president and CEO of Corautus, in a statement. “We believe that NASDAQ’s multiple market maker system will help us achieve these goals and\ position us among other innovative companies with clinical-stage programs who are part of The NASDAQ Stock Market.”